Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer

Overview of attention for article published in Drug Design, Development and Therapy, August 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 1 YouTube video.

Video abstract of review paper Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer…